News

Press Release

bit.bio CEO wins in 2 categories at Great British Entrepreneur Awards

Mark Kotter wins in two categories, Equity-Backed Entrepreneur of the Year and Purpose Entrepreneur of the Year, at the Great British Entrepreneur Awards.

21.11.2023

Published by bit.bio

Mark Kotter wins in two categories, Equity-Backed Entrepreneur of the Year and Purpose Entrepreneur of the Year, at the Great British Entrepreneur Awards.

Published by bit.bio

Read now

Press Release

bit.bio unveils cell therapy pipeline, lead candidate and expanded SAB

Lead candidate is encapsulated allogeneic txHepatocytes for treatment of acute liver failure, SAB expanded to include 3 global exp...

08.11.2023

Published by bit.bio

Read now

Press Release

Product launch | CRISPR-Ready ioGlutamatergic Neurons

bit.bio launches first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the way for new advances in disease m...

17.10.2023

Published by bit.bio

Read now

Press Release

Synthego and bit.bio expand strategic partnership

Partnership to build a platform for the development of safer and more efficient genetic engineering of human cells for cell therap...

24.08.2023

Published by bit.bio

Read now

Press Release

BlueRock Therapeutics and bit.bio announce collaboration

BlueRock Therapeutics and bit.bio announce collaboration and option agreement for the discovery & manufacture of regulatory T cell...

03.08.2023

Published by bit.bio

Read now

Press Release

Foundational US patent secured for bit.bio's opti-ox technology

bit.bio secures foundational United States patent for opti-ox, its cell programming technology that uses genomic safe harbour site...

26.07.2023

Published by bit.bio

Read now

Press Release

Two new disease models for Duchenne muscular dystrophy

bit.bio launches two new human cell disease models to advance discovery and development of treatments for Duchenne muscular dystro...

12.07.2023

Published by bit.bio

Read now

Press Release

bit.bio is industrialising human cell manufacturing

Industrialising human cell manufacturing will unleash the potential of synthetic biology for reproducible research and affordable ...

15.06.2023

Published by bit.bio

Read now

Press Release

bit.bio launches new custom disease model cells offering, advancing disease research & drug discovery

Offering will provide robust, standardised tools for research and drug discovery.

23.05.2023

Published by bit.bio

Read now

Related pages